The binding of [3H]AF-DX 384 is reduced in the caudate-putamen of subjects with schizophrenia
References (39)
- et al.
Schizoph. Res.
(1991) - et al.
Neuropharmacol.
(1991) - et al.
Psychiatry Res.
(1990) - et al.
Biol. Psychiatry.
(1994) - et al.
Europ. J. Pharmacol.
(1991) - et al.
Brain Res.
(1986) - et al.
Euro. J. Pharmacol.
(1992) - et al.
FEBS Lett.
(1988) - et al.
Euro. J. Pharmacol.
(1994) - et al.
Neuroscience
(1983)
Life Science.
(1983)
Science In China
(1993)
Pharmazie.
(1994)
Eur. J. Pharmacol.
(1994)
J. Psychiat. Res.
(1974)
Arch. Gen. Psychiatry.
(1974)
Br. J. Psychiatry.
(1983)
Molec. Psychiatry.
(1996)
Eur. J. Pharmacol.
(1994)
Cited by (0)
- ∗
Dr Jeremy M. Crook: The Rebecca L. Cooper Research Laboratories, The Mental Health Research Institute of Victoria, Locked Bag 11, Parkville, Victoria, 3052, Australia. telephone: (03) 93881633; fax: (03) 93875061.
Copyright © 1999 Published by Elsevier Inc.